Sublingual Adjuvant Delivery by a Live Attenuated <named-content content-type="genus-species">Vibrio cholerae</named-content>-Based Antigen Presentation Platform

ABSTRACT A sublingually delivered heterologous antigen presentation platform that does not depend on antigen or adjuvant purification would be of great benefit in protection against diarrheal disease. In proof-of-concept studies, we previously showed that when a fusion protein comprised of the Vibri...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Julie Liao, Jacob A. Gibson, Bradley S. Pickering, Paula I. Watnick
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2018
Materias:	Vibrio cholerae cholera toxin adjuvants live vector vaccines mmCT vaccine vaccine platform Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/1e1c5a5ab6d047e39d99730359226319
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1e1c5a5ab6d047e39d99730359226319
record_format	dspace
spelling	oai:doaj.org-article:1e1c5a5ab6d047e39d997303592263192021-11-15T15:24:22ZSublingual Adjuvant Delivery by a Live Attenuated <named-content content-type="genus-species">Vibrio cholerae</named-content>-Based Antigen Presentation Platform10.1128/mSphere.00245-182379-5042https://doaj.org/article/1e1c5a5ab6d047e39d997303592263192018-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00245-18https://doaj.org/toc/2379-5042ABSTRACT A sublingually delivered heterologous antigen presentation platform that does not depend on antigen or adjuvant purification would be of great benefit in protection against diarrheal disease. In proof-of-concept studies, we previously showed that when a fusion protein comprised of the Vibrio cholerae biofilm matrix protein RbmA and the B subunit of cholera toxin (R-CTB) is expressed from a plasmid within V. cholerae, R-CTB is sequestered in the biofilm matrix, leading to decoration of the cell surface. Sublingual delivery of live attenuated R-CTB-decorated cells results in a mucosal immune response to CTB. To improve the immune response to diarrheal antigens presented by this platform, we have engineered our live attenuated vaccine to express the mucosal adjuvant mmCT (i.e., multiply mutated CT). Here we report that delivery of this adjuvant via sublingual administration of our vaccine enhances the mucosal immune response to V. cholerae LPS and elicits a systemic and mucosal immune response to CTB. However, provision of R-CTB with mmCT selectively blunts the mucosal immune response to CTB. We propose that mmCT delivered by this live attenuated Vibrio cholerae vaccine platform may serve as a mucosal adjuvant for heterologous antigens, provided they are not too similar to mmCT. IMPORTANCE Diarrheal disease is the most common infectious disease of children in the developing world. Our goal is to develop a diarrheal antigen presentation platform based on whole Vibrio cholerae cells that does not depend on protein purification. We have previously shown the feasibility of genetically fusing antigens to the V. cholerae biofilm matrix protein RbmA for presentation on the cell surface. A mucosal adjuvant could improve immunogenicity of such a vaccine at the mucosal surface. Here we engineer a live attenuated V. cholerae vaccine to constitutively synthesize mmCT, a nontoxic form of cholera toxin. When this vaccine is delivered sublingually, in vivo-synthesized mmCT acts as both an adjuvant and antigen. This could greatly increase the magnitude and duration of the immune response elicited by codelivered heterologous antigens.Julie LiaoJacob A. GibsonBradley S. PickeringPaula I. WatnickAmerican Society for MicrobiologyarticleVibrio choleraecholera toxin adjuvantslive vector vaccinesmmCTvaccinevaccine platformMicrobiologyQR1-502ENmSphere, Vol 3, Iss 3 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Vibrio cholerae cholera toxin adjuvants live vector vaccines mmCT vaccine vaccine platform Microbiology QR1-502
spellingShingle	Vibrio cholerae cholera toxin adjuvants live vector vaccines mmCT vaccine vaccine platform Microbiology QR1-502 Julie Liao Jacob A. Gibson Bradley S. Pickering Paula I. Watnick Sublingual Adjuvant Delivery by a Live Attenuated <named-content content-type="genus-species">Vibrio cholerae</named-content>-Based Antigen Presentation Platform
description	ABSTRACT A sublingually delivered heterologous antigen presentation platform that does not depend on antigen or adjuvant purification would be of great benefit in protection against diarrheal disease. In proof-of-concept studies, we previously showed that when a fusion protein comprised of the Vibrio cholerae biofilm matrix protein RbmA and the B subunit of cholera toxin (R-CTB) is expressed from a plasmid within V. cholerae, R-CTB is sequestered in the biofilm matrix, leading to decoration of the cell surface. Sublingual delivery of live attenuated R-CTB-decorated cells results in a mucosal immune response to CTB. To improve the immune response to diarrheal antigens presented by this platform, we have engineered our live attenuated vaccine to express the mucosal adjuvant mmCT (i.e., multiply mutated CT). Here we report that delivery of this adjuvant via sublingual administration of our vaccine enhances the mucosal immune response to V. cholerae LPS and elicits a systemic and mucosal immune response to CTB. However, provision of R-CTB with mmCT selectively blunts the mucosal immune response to CTB. We propose that mmCT delivered by this live attenuated Vibrio cholerae vaccine platform may serve as a mucosal adjuvant for heterologous antigens, provided they are not too similar to mmCT. IMPORTANCE Diarrheal disease is the most common infectious disease of children in the developing world. Our goal is to develop a diarrheal antigen presentation platform based on whole Vibrio cholerae cells that does not depend on protein purification. We have previously shown the feasibility of genetically fusing antigens to the V. cholerae biofilm matrix protein RbmA for presentation on the cell surface. A mucosal adjuvant could improve immunogenicity of such a vaccine at the mucosal surface. Here we engineer a live attenuated V. cholerae vaccine to constitutively synthesize mmCT, a nontoxic form of cholera toxin. When this vaccine is delivered sublingually, in vivo-synthesized mmCT acts as both an adjuvant and antigen. This could greatly increase the magnitude and duration of the immune response elicited by codelivered heterologous antigens.
format	article
author	Julie Liao Jacob A. Gibson Bradley S. Pickering Paula I. Watnick
author_facet	Julie Liao Jacob A. Gibson Bradley S. Pickering Paula I. Watnick
author_sort	Julie Liao
title	Sublingual Adjuvant Delivery by a Live Attenuated <named-content content-type="genus-species">Vibrio cholerae</named-content>-Based Antigen Presentation Platform
title_short	Sublingual Adjuvant Delivery by a Live Attenuated <named-content content-type="genus-species">Vibrio cholerae</named-content>-Based Antigen Presentation Platform
title_full	Sublingual Adjuvant Delivery by a Live Attenuated <named-content content-type="genus-species">Vibrio cholerae</named-content>-Based Antigen Presentation Platform
title_fullStr	Sublingual Adjuvant Delivery by a Live Attenuated <named-content content-type="genus-species">Vibrio cholerae</named-content>-Based Antigen Presentation Platform
title_full_unstemmed	Sublingual Adjuvant Delivery by a Live Attenuated <named-content content-type="genus-species">Vibrio cholerae</named-content>-Based Antigen Presentation Platform
title_sort	sublingual adjuvant delivery by a live attenuated <named-content content-type="genus-species">vibrio cholerae</named-content>-based antigen presentation platform
publisher	American Society for Microbiology
publishDate	2018
url	https://doaj.org/article/1e1c5a5ab6d047e39d99730359226319
work_keys_str_mv	AT julieliao sublingualadjuvantdeliverybyaliveattenuatednamedcontentcontenttypegenusspeciesvibriocholeraenamedcontentbasedantigenpresentationplatform AT jacobagibson sublingualadjuvantdeliverybyaliveattenuatednamedcontentcontenttypegenusspeciesvibriocholeraenamedcontentbasedantigenpresentationplatform AT bradleyspickering sublingualadjuvantdeliverybyaliveattenuatednamedcontentcontenttypegenusspeciesvibriocholeraenamedcontentbasedantigenpresentationplatform AT paulaiwatnick sublingualadjuvantdeliverybyaliveattenuatednamedcontentcontenttypegenusspeciesvibriocholeraenamedcontentbasedantigenpresentationplatform
_version_	1718427934997348352

Sublingual Adjuvant Delivery by a Live Attenuated <named-content content-type="genus-species">Vibrio cholerae</named-content>-Based Antigen Presentation Platform

Ejemplares similares